May 23, 2011 is a day to remember. The cannabis grassroots communities of ASA, CRC, and Patients out of time have united with the previous assertions by the American Medical Association and the American College of Physicians in a lawsuit against the United States government to forcibly reclassify cannabis to a schedule 3 drug rather than the schedule 1 it currently holds. Schedule 1 means there is no medical use and it has a high propensity for abuse.
In a confusing twist – laboratories and pharmaceutical companies have been creating synthetic THC for years. Synthetic/fake THC is called dronabinol (Schedule 3 – Medical use with low propensity for abuse) The DEA accepted a petition in 2002 that would make cannabis a schedule 3 as well. “On average, it takes 6 months from HHS review to final action, whereas it’s been nearly 5 years since HHS issued its recommendation on the CRC petition, more than twice as long as any other rescheduling petition reviewed since 2002.”(Wiki)
To push the obama administration to answer the decade old petition to reclassify medical marijuana patients and patient advocacy groups have united and filed suit in the Washington DC Circuit Court on May 23. There is massive evidence to corroborate their case including peer reviewed scientific studies, the proven long term non dangerousness of the drug as well as its unbelievable effectiveness.
Although the feds have held their position, 16 states as well as the District of Colombia have decriminalized cannabis. The DEA’s own Administrative Law Judge Francis Young recommended in favor of reclassification stating that, “Marijuana, in its natural form, is one of the safest therapeutically active substances known to man.” Beyond that, some national polls have shown that upwards of 80% of Americans are in favor of reclassification and decriminalization.
If the case is questioned in its efficacy marijuana will be finally proven in federal court as an effective and therapeutic drug, it is is not challenged.. it will be accepted in court as an effective and therapeutic drug… Both GREAT options!
Stay tuned for more!